Showing results 1 to 7 of 7
An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide Kim, Daejin; Jeon, Hyungsu; Ahn, Sukyung; Choi, Won Il; Kim, Sunghyun; Jon, Sangyong, JOURNAL OF CONTROLLED RELEASE, v.256, pp.114 - 120, 2017-06 |
An Integrated View of Immunometabolism Lee, Yun Sok; Wollam, Joshua; Olefsky, Jerrold M., CELL, v.172, no.1-2, pp.22 - 40, 2018-01 |
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Oh, Yumin; Park, Jong-Sung; Kwon, Seung-Hwan; et al, NATURE MEDICINE, v.24, no.7, pp.931 - +, 2018-07 |
Disruption of CR6-interacting factor-1 (CRIF1) in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failure Kim, Yong Kyung; Joung, Kyong Hye; Ryu, Min Jeong; Kim, Soung Jung; Kim, Hyeongseok; Chung, Hyo Kyun; Lee, Min Hee; et al, DIABETOLOGIA, v.58, no.4, pp.771 - 780, 2015-04 |
Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan Ahn, Sukyung; Lee, In-Hyun; Lee, Eunhye; Kim, Hyungjun; Kim, Yong-Chul; Jon, Sangyong, JOURNAL OF CONTROLLED RELEASE, v.170, no.2, pp.226 - 232, 2013-09 |
Prolonged half-life of small-sized therapeutic protein using serum albumin-specific protein binder Kim, Tae Yoon; Park, Jin Ho; Shim, Ha Eun; Choi, Dae Seong; Lee, Dong-Eun; Song, Ji-Joon; Kim, Hak-Sung, JOURNAL OF CONTROLLED RELEASE, v.315, pp.31 - 39, 2019-12 |
Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility Lee, Jung Gi; Ryu, Jae Ha; Kim, Seon-Myung; Park, Moon-Young; Kim, San-Ho; Shin, Young G.; Sohn, Jong Woo; et al, BIOCHEMICAL PHARMACOLOGY, v.151, pp.59 - 68, 2018-05 |
Discover